Home

Pacira BioSciences, Inc. - Common Stock (PCRX)

26.02
-0.22 (-0.84%)

Pacira Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative non-opioid pain management solutions

The company is dedicated to improving patient outcomes by offering products that mitigate post-surgical pain while minimizing the reliance on traditional opioid medications. Pacira's lead product is designed for effective local anesthetic delivery, aiming to enhance recovery experiences for patients undergoing various surgical procedures. Through its commitment to research and development, Pacira seeks to advance medical practices in pain management and promote safer alternatives for both healthcare providers and patients.

SummaryNewsPress ReleasesChartHistoricalFAQ

Frequently Asked Questions

Is Pacira BioSciences, Inc. - Common Stock publicly traded?
Yes, Pacira BioSciences, Inc. - Common Stock is publicly traded.
What exchange does Pacira BioSciences, Inc. - Common Stock trade on?
Pacira BioSciences, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Pacira BioSciences, Inc. - Common Stock?
The ticker symbol for Pacira BioSciences, Inc. - Common Stock is PCRX on the Nasdaq Stock Market
What is the current price of Pacira BioSciences, Inc. - Common Stock?
The current price of Pacira BioSciences, Inc. - Common Stock is 26.02
When was Pacira BioSciences, Inc. - Common Stock last traded?
The last trade of Pacira BioSciences, Inc. - Common Stock was at 3:33 pm EST on January 31st, 2025
What is the market capitalization of Pacira BioSciences, Inc. - Common Stock?
The market capitalization of Pacira BioSciences, Inc. - Common Stock is 1.16B
How many shares of Pacira BioSciences, Inc. - Common Stock are outstanding?
Pacira BioSciences, Inc. - Common Stock has 44.45M shares outstanding.